These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 15586315

  • 1. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
    Naber D, Lambert M, Karow A.
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
    [Abstract] [Full Text] [Related]

  • 2. Subjective well-being and quality of life under atypical antipsychotic treatment.
    Karow A, Naber D.
    Psychopharmacology (Berl); 2002 Jun; 162(1):3-10. PubMed ID: 12107610
    [Abstract] [Full Text] [Related]

  • 3. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):703-12. PubMed ID: 17289237
    [Abstract] [Full Text] [Related]

  • 4. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
    Burton S.
    J Psychopharmacol; 2006 Nov 13; 20(6 Suppl):6-19. PubMed ID: 17046984
    [Abstract] [Full Text] [Related]

  • 5. Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics.
    Watanabe A, Shibata I, Kato T.
    Psychiatry Clin Neurosci; 2004 Jun 13; 58(3):268-73. PubMed ID: 15149292
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
    Chue P.
    J Psychopharmacol; 2006 Nov 13; 20(6 Suppl):38-56. PubMed ID: 17046986
    [Abstract] [Full Text] [Related]

  • 9. [Subjective view of positive symptoms and quality of life in patients with schizophrenia].
    Karow A, Schäfer I, Hirdes F, Osterwald C, Naber D.
    Psychiatr Prax; 2008 Sep 13; 35(6):286-93. PubMed ID: 18504688
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A, Rettenbacher MA, Edlinger M, Kemmler G, Widschwendter CG, Fleischhacker WW.
    Acta Psychiatr Scand; 2007 Nov 13; 116(5):354-61. PubMed ID: 17868428
    [Abstract] [Full Text] [Related]

  • 15. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC.
    J Nerv Ment Dis; 2002 Sep 13; 190(9):597-603. PubMed ID: 12357093
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
    Kasper S.
    Eur Neuropsychopharmacol; 2006 Sep 13; 16 Suppl 3():S135-41. PubMed ID: 16872809
    [Abstract] [Full Text] [Related]

  • 20. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W, Kilian R, Toumi M, Angermeyer MC.
    Pharmacopsychiatry; 2003 May 13; 36(3):105-12. PubMed ID: 12806568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.